EE9900593A - Omeprasooli naatriumisool - Google Patents

Omeprasooli naatriumisool

Info

Publication number
EE9900593A
EE9900593A EEP199900593A EEP9900593A EE9900593A EE 9900593 A EE9900593 A EE 9900593A EE P199900593 A EEP199900593 A EE P199900593A EE P9900593 A EEP9900593 A EE P9900593A EE 9900593 A EE9900593 A EE 9900593A
Authority
EE
Estonia
Prior art keywords
sodium salt
omeprazole sodium
omeprazole
salt
sodium
Prior art date
Application number
EEP199900593A
Other languages
English (en)
Inventor
Gustavsson Anders
Kjellbom Kristina
Ymn Ingvar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900593A publication Critical patent/EE9900593A/et
Publication of EE03613B1 publication Critical patent/EE03613B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP199900593A 1997-06-27 1998-06-11 Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks EE03613B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702483A SE510643C2 (sv) 1997-06-27 1997-06-27 Termodynamiskt stabil omeprazol natrium form B
PCT/SE1998/001124 WO1999000380A1 (en) 1997-06-27 1998-06-11 Omeprazole sodium salt

Publications (2)

Publication Number Publication Date
EE9900593A true EE9900593A (et) 2000-08-15
EE03613B1 EE03613B1 (et) 2002-02-15

Family

ID=20407555

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900593A EE03613B1 (et) 1997-06-27 1998-06-11 Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks

Country Status (34)

Country Link
US (1) US6207188B1 (et)
EP (2) EP1186602A3 (et)
JP (1) JP3377218B2 (et)
KR (1) KR100580987B1 (et)
CN (1) CN1134432C (et)
AR (1) AR013350A1 (et)
AT (1) ATE233756T1 (et)
AU (1) AU750239B2 (et)
BR (1) BR9810483A (et)
CA (1) CA2294614C (et)
CZ (1) CZ296723B6 (et)
DE (1) DE69811892T2 (et)
DK (1) DK0991641T3 (et)
EE (1) EE03613B1 (et)
EG (1) EG24224A (et)
ES (1) ES2191944T3 (et)
HU (1) HU227976B1 (et)
ID (1) ID24829A (et)
IL (2) IL133559A0 (et)
IS (1) IS1946B (et)
MY (1) MY127871A (et)
NO (1) NO318245B1 (et)
NZ (1) NZ501929A (et)
PL (1) PL190869B1 (et)
PT (1) PT991641E (et)
RU (1) RU2186778C2 (et)
SA (1) SA98190410B1 (et)
SE (1) SE510643C2 (et)
SK (1) SK283958B6 (et)
TR (1) TR199903270T2 (et)
TW (1) TW483758B (et)
UA (1) UA58556C2 (et)
WO (1) WO1999000380A1 (et)
ZA (1) ZA985317B (et)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
GB2324093A (en) 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
WO2000071122A1 (en) * 1999-05-20 2000-11-30 Par Pharmaceutical, Inc. Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
EP1706397A4 (en) * 2000-05-15 2007-08-01 Ranbaxy Lab Ltd AMORPHOUS FORM OF OMEPRAZOLE SALTS
CA2417311C (en) * 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
CA2419067C (en) 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP1411900B2 (en) * 2001-06-01 2013-12-04 Pozen, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
AU2003278406A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
US20070060556A1 (en) 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
CA2570795C (en) * 2004-06-24 2013-05-28 Astrazeneca Ab Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
WO2006131338A2 (en) * 2005-06-08 2006-12-14 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CN101412710B (zh) * 2008-12-16 2010-04-21 海南百那医药发展有限公司 一种奥美拉唑钠化合物及其制法
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US20110008432A1 (en) * 2009-06-25 2011-01-13 Pozen Inc. Method for Treating a Patient in Need of Aspirin Therapy
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102512380B (zh) * 2011-12-20 2013-04-17 海南锦瑞制药股份有限公司 一种以奥美拉唑钠为活性成分的冻干粉针剂及其制备方法
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
CN102827147B (zh) * 2012-09-13 2013-08-07 山东罗欣药业股份有限公司 一种奥美拉唑钠晶体化合物及含有该晶体化合物的药物组合物
CN102871973A (zh) * 2012-10-16 2013-01-16 浙江亚太药业股份有限公司 一种奥美拉唑钠冻干制剂及其制备方法
CN103012371B (zh) * 2013-01-05 2014-02-12 宁辉 奥美拉唑钠结晶化合物、其制备方法及其药物组合物
CN103570687B (zh) * 2013-11-15 2015-01-07 悦康药业集团有限公司 一种奥美拉唑钠晶体化合物
CN104788426B (zh) * 2015-04-02 2015-12-30 天津大学 一种奥美拉唑钠半水合物及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification
CN116041325B (zh) * 2022-12-09 2025-03-07 山东北大高科华泰制药有限公司 稳定化质子泵抑制剂的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2719916C2 (de) * 1977-05-04 1987-03-19 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decanen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
ES2023778A6 (es) * 1990-12-12 1992-02-01 Genesis Para La Investigacion Procedimiento para preparar sales alcalinas del omeprazol
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
CZ289804B6 (cs) 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
CN1042423C (zh) * 1995-05-25 1999-03-10 常州市第四制药厂 奥美拉唑盐水合物及其制备方法
WO1998040377A1 (en) * 1997-03-07 1998-09-17 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-[[(2-pyridinyl)methyl]sulfinyl]-1h-benzimidazoles and novel compounds of use for such purpose
AU5982298A (en) * 1997-03-07 1998-09-29 A/S Gea Farmaceutisk Fabrik Process for the preparation of 2-{{(2-pyridinyl)me thyl}sulfinyl}-1h-benzimidazoles and novel compounds of use for such purpos
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
NO318245B1 (no) 2005-02-21
IS1946B (is) 2004-10-13
WO1999000380A1 (en) 1999-01-07
US6207188B1 (en) 2001-03-27
DE69811892D1 (de) 2003-04-10
CA2294614C (en) 2002-01-08
KR100580987B1 (ko) 2006-05-17
HUP0003017A2 (hu) 2001-06-28
AU750239B2 (en) 2002-07-11
RU2186778C2 (ru) 2002-08-10
CN1261362A (zh) 2000-07-26
EP0991641A1 (en) 2000-04-12
DE69811892T2 (de) 2004-03-04
ID24829A (id) 2000-08-24
CA2294614A1 (en) 1999-01-07
PT991641E (pt) 2003-06-30
NZ501929A (en) 2001-06-29
SE9702483D0 (sv) 1997-06-27
EP1186602A3 (en) 2002-03-27
NO996440L (no) 2000-02-08
IL133559A (en) 2006-04-10
HK1026699A1 (en) 2000-12-22
MY127871A (en) 2006-12-29
NO996440D0 (no) 1999-12-23
BR9810483A (pt) 2000-09-12
DK0991641T3 (da) 2003-05-19
EE03613B1 (et) 2002-02-15
SE510643C2 (sv) 1999-06-14
IS5314A (is) 1999-12-21
JP2001508805A (ja) 2001-07-03
PL190869B1 (pl) 2006-02-28
ZA985317B (en) 1999-01-11
CZ296723B6 (cs) 2006-05-17
TW483758B (en) 2002-04-21
JP3377218B2 (ja) 2003-02-17
TR199903270T2 (xx) 2000-07-21
HU227976B1 (en) 2012-07-30
UA58556C2 (uk) 2003-08-15
AR013350A1 (es) 2000-12-27
CZ469999A3 (cs) 2000-08-16
SA98190410B1 (ar) 2006-06-10
SE9702483L (sv) 1998-12-28
KR20010014165A (ko) 2001-02-26
SK283958B6 (sk) 2004-06-08
AU8135398A (en) 1999-01-19
EP0991641B1 (en) 2003-03-05
ES2191944T3 (es) 2003-09-16
EP1186602A2 (en) 2002-03-13
EG24224A (en) 2008-11-10
SK172999A3 (en) 2000-07-11
PL337735A1 (en) 2000-08-28
CN1134432C (zh) 2004-01-14
ATE233756T1 (de) 2003-03-15
HUP0003017A3 (en) 2002-01-28
IL133559A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
NO996440L (no) Omeprazol-natriumsalt
DK1005446T3 (da) N-aroylphenylalaninderivater
ATE235220T1 (de) Resorcinderivate
ID22781A (id) Turunan-turunan nikotinamida
ATE284385T1 (de) Sulfonamidderivate
DE69817186D1 (de) Diaminorhodamin-derivate
DE59712204D1 (de) Radaufhängung
DE69802569D1 (de) Aufhängungseinrichtung
DK0958282T3 (da) 2-Amino-6-(2-substitueret-4-phenoxy)-substitueret-pyridiner
FI20000850L (fi) Kamana
ATE255098T1 (de) Substituierte chromanderivate
DE69805807D1 (de) Mikrobiozide n-sulfonylglycin-alkynyloxyphenethylamid-derivate
ATE440854T1 (de) 5-deoxy-cytidin-derivate
ATE255099T1 (de) Substituierte chromanderivate
DK0966437T3 (da) 5-Aroylnaphthalenderivater
ID18027A (id) Garam amina
NO995853D0 (no) Nytt salt
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
ATE241275T1 (de) Phosphoniumsalz-zusammensetzung
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495L (no) Fenoksymetylpiperidin-derivater
DE69813264D1 (de) Kleiderbügel
DE69824255D1 (de) Deformylase
DK1015447T3 (da) Piperidinylmethyloxazolidinonderivat
DE69814731D1 (de) Kleiderbügel

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160611